Filing Details

Accession Number:
0000315066-22-001561
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-14 17:13:02
Reporting Period:
2022-04-12
Accepted Time:
2022-04-14 17:13:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1745999 Beam Therapeutics Inc. BEAM () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
315066 Fmr Llc 245 Summer Street
Boston MA 02210
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-04-12 978,503 $0.00 2,935,511 No 4 J Indirect F-Prime Capital Partners Healthcare Fund V LP
Common Stock Acquisiton 2022-04-12 509,490 $0.00 509,995 No 4 J Indirect Impresa Fund III Limited Partnership
Common Stock Disposition 2022-04-12 509,332 $0.00 663 No 4 J Indirect Impresa Fund III Limited Partnership
Common Stock Acquisiton 2022-04-12 137,845 $0.00 141,151 No 4 J Indirect F-Prime Capital Partners Healthcare Advisors Fund V LP
Common Stock Disposition 2022-04-12 128,333 $0.00 12,818 No 4 J Indirect F-Prime Capital Partners Healthcare Advisors Fund V LP
Common Stock Acquisiton 2022-04-12 15,406 $0.00 18,803 No 4 J Indirect F-Prime Inc.
Common Stock Acquisiton 2022-04-12 422,120 $0.00 2,490,515 No 4 J Indirect Shares held by persons and entities whose shares are subject to reporting by the undersigned.
Common Stock Disposition 2022-04-13 663 $50.75 0 No 4 S Indirect Impresa Fund III Limited Partnership
Common Stock Disposition 2022-04-13 6,799 $50.70 12,004 No 4 S Indirect F-Prime Inc.
Common Stock Disposition 2022-04-13 8,804 $50.01 3,200 No 4 S Indirect F-Prime Inc.
Common Stock Disposition 2022-04-13 3,200 $50.80 0 No 4 S Indirect F-Prime Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Indirect F-Prime Capital Partners Healthcare Fund V LP
No 4 J Indirect Impresa Fund III Limited Partnership
No 4 J Indirect Impresa Fund III Limited Partnership
No 4 J Indirect F-Prime Capital Partners Healthcare Advisors Fund V LP
No 4 J Indirect F-Prime Capital Partners Healthcare Advisors Fund V LP
No 4 J Indirect F-Prime Inc.
No 4 J Indirect Shares held by persons and entities whose shares are subject to reporting by the undersigned.
No 4 S Indirect Impresa Fund III Limited Partnership
No 4 S Indirect F-Prime Inc.
No 4 S Indirect F-Prime Inc.
No 4 S Indirect F-Prime Inc.
Footnotes
  1. These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.
  2. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $50.50 to $51.00. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $49.75 to $50.50. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.